SCHEMBL19166301

SCHEMBL19166301

CC1(C)c2ccccc2-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc4c(c3)-c3ccccc3-c3ccccc3C43c4ccccc4-c4ccccc43)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 6/20 0.35
▸ MEN1 O00255 1/20 0.32
▸ APAF1 O14727 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ XBP1 P17861 1/20 0.32
▸ PTBP1 P26599 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ GALK1 P51570 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ SMAD3 P84022 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MLNR O43193 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19168879 1.00 PDK2 (0.35) PDK2MEN1APAF1NPC1LMNA
SCHEMBL24750395 0.99 PDK2 (0.36) PDK2MEN1LMNAMAPTKMT2A
SCHEMBL24647072 0.99 PDK2 (0.36) PDK2MEN1LMNAMAPTKMT2A
SCHEMBL24646699 0.99 PDK2 (0.36) PDK2MEN1LMNAMAPTKMT2A
SCHEMBL15213630 0.99 PDK2 (0.36) PDK2MEN1LMNAMAPTKMT2A
SCHEMBL24750858 0.99 PDK2 (0.36) PDK2MEN1LMNAMAPTKMT2A
SCHEMBL21559025 0.97 PDK2 (0.35) PDK2MLNRNR1I2CHRM2ADRB1
SCHEMBL21922838 0.97 PDK2 (0.37) PDK2MAPTL3MBTL1MLNRNR1I2
SCHEMBL21922840 0.97 PDK2 (0.37) PDK2MAPTL3MBTL1MLNRNR1I2
SCHEMBL19011253 0.97 PDK2 (0.35) PDK2MLNRNR1I2CHRM2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10424744-B2 Compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-09-24 — — US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 — — US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10424744-B2 Compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 PDK2 2514/4885MEN1 305/4885APAF1 3170/4885
US-20170213971-A1 Novel compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 PDK2 2806/4885MEN1 251/4885APAF1 3066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback